Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ena-DATASET-MUG-24-06-2016-10:36:41:861-335 - samples

ABSTRACT: Merged file of low-coverage WGS from 179 plasma DNA samples from non-cancer controls and cancer patients for assessment of size distribution of plasma nuclear DNA fragments.

PROVIDER: EGAD00001002217 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Publications

Inferring expressed genes by whole-genome sequencing of plasma DNA.

Ulz Peter P Thallinger Gerhard G GG Auer Martina M Graf Ricarda R Kashofer Karl K Jahn Stephan W SW Abete Luca L Pristauz Gunda G Petru Edgar E Geigl Jochen B JB Heitzer Ellen E Speicher Michael R MR

Nature genetics 20160829 10

The analysis of cell-free DNA (cfDNA) in plasma represents a rapidly advancing field in medicine. cfDNA consists predominantly of nucleosome-protected DNA shed into the bloodstream by cells undergoing apoptosis. We performed whole-genome sequencing of plasma DNA and identified two discrete regions at transcription start sites (TSSs) where nucleosome occupancy results in different read depth coverage patterns for expressed and silent genes. By employing machine learning for gene classification, w ...[more]

PMID: 27571261

Similar Datasets

Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma

Project description:Background: Cell free DNA (cfDNA) in plasma has received increasing attention and has been studied in a broad range of clinical conditions implicating inflammation, cancer, and aging. However, few studies have focused on mitochondrial DNA (mtDNA) in the cell free form. This study characterized the size distribution and sequence characteristics of plasma cell free mtDNA (cf mtDNA) in humans.Methods and Results: We optimized DNA isolation and next-generation sequencing library preparation protocols to better retain short DNA fragments from plasma, and applied these optimized methods to plasma samples from patients with sepsis. After massive parallel sequencing, we verified that our methods can retain substantially shorter DNA fragments than the standard isolation method, resulting in an average of 11.5 fold increase in short DNA fragments yield (DNA < 100bp). We report that cf mtDNA in plasma is highly enriched in short-size cfDNA (30 ~ 60 bp), which is much shorter than the value previously reported (~140 bp). Motivated by this unique size distribution, we size-selected short cfDNA fragments from the sequencing library, which further increased the mtDNA recovery rate by an average of 10.4 fold. Using this approach we detected mixtures of different mtDNA sequences, termed heteroplasmy, in plasma from 3 patients. In one patient who previously received bone marrow transplantation, different minor allele frequencies were observed between plasma and white blood cells (WBC) at heteroplasmic mtDNA sites, consistent with mixed-tissue origin for plasma DNA.Conclusion: mtDNA in plasma exists as very short fragments that exhibit mtDNA heteroplasmy distribution differences from that found in a single organ/tissue. This study is the first report of genome wide identification of mtDNA heteroplasmy in human plasma. Our optimized method can be used to investigate the potential utility of cf mtDNA fragments and heteroplasmy as biomarkers in various diseases.

2016-05-07 | GSE81178 | GEO

Homo sapiens

Project description:Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma

| PRJNA320827 | ENA

Next-generation sequencing of Okazaki fragments extracted from Saccharomyces cerevisiae

Project description:We investigated the genome-wide distribution of Okazaki fragments in the commonly used laboratory Saccharomyces cerevisiae strain S288C to study the DNA replication model adopted by the budding yeast. The method based upon lambda exonuclease digestion for purification of RNA-primed replication intermediates was first improved to be suitable for the purification of Okazaki fragments. Then, we used this improved method to purify Okazaki fragments from S288C yeast cells, followed by Illumina sequencing. We found that the expected asymmetric distribution of Okazaki fragments around confirmed replication origins, which was derived from the semi-discontinuous DNA replication model, was not observed on S. cerevisiae chromosomes. Even around two highly efficient replication origins, ARS522 and ARS416, the ratios of Okazaki fragments on both strands were inconsistent with the semi-discontinuous DNA replication model. Our study supported the discontinuous DNA replication model. Besides, we also observed that Okazaki fragments were overpresented in the transcribed regions in S. cerevisiae mitochondrial genome, which indicated the interplay between transcription and DNA replication.

2013-06-18 | GSE42929 | GEO

Next-generation sequencing of Okazaki fragments extracted from Saccharomyces cerevisiae

2013-06-18 | E-GEOD-42929 | biostudies-arrayexpress

ena-DATASET-MUG-14-07-2016-11:57:14:452-1424 - samples

Project description:Single-end sequencing data (trimmed to 60bp) of 104 plasma samples from donors without tumors (male=50; female=54) were merged and used to establish coverage profiles around the TSS and to establish a gene expression prediction algorithm. Dataset includes merged alignements of low coverage whole genome sequencing from plasma DNA from 50 male, 54 female non-cancer donors. Furthermore, 2 patients with metastasized breast cancer were sequenced on a NextSeq with higher depth.

| EGAD00001002254 | EGA

Identify the binding protein of a 41-bp DNA sequence harboring rs2431697

Project description:we performed DNA-affinity precipitation assay (DAPA) followed by mass spectrometry to identify the possible candidates that specifically bind to the 41-bp nucleotide sequence containing rs2431697 using U-937 cell nuclear extracts.

2020-12-14 | PXD021334 | Pride

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

Project description:The purpose of this study is to use the SignateraTm assay created from rectal tumor biopsies to monitor participants’ blood for fragments of DNA shed by tumor cells. The tumor DNA fragments are referred to as circulating tumor DNA, or ctDNA for short.

| 2720974 | ecrin-mdr-crc

ena-DATASET-MUG-24-06-2016-09:45:40:262-333 - samples

Project description:Low coverage whole genome sequencing plasma DNA from 50 male, 54 female non-cancer donors. For the analysis of nucleosomal positioning all data from the non-cancer controls were merged. Furthermore, two patients with metastasized breast cancer were sequenced on a NextSeq with higher depth.

| EGAD00001002215 | EGA

K450 arrays leukocyte subsets

Project description:DNA methylation profiles of primary human leukocyte subsets. Complementary MeDIP-seq data for the same samples have been deposited in ArrayExpress under accession number E-ERAD-179 (https://www.ebi.ac.uk/arrayexpress/experiments/E-ERAD-179/) .

2013-12-09 | E-MTAB-2145 | biostudies-arrayexpress

identify the possible candidates that specifically bind to the 41-bp nucleotide sequence containing rs2431697

2020-11-04 | PXD021335 | Pride